Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the EASL 2024 Annual Meeting and International Liver Congress. This event, taking place from 5th to 8th June2024 at the MiCo Milano Convention Centre in Milan, Italy, is a key gathering for hepatology experts.
If you would like to connect with Dr. Taubel during the event, please reach out to arrange a meeting.
Medicines Marketing UK / EU vs US: Why Your Launch Strategy Needs a Continental Divide - Dr Lisa Campbell, Director of Regulatory Strategy
September 12, 2025
A UK CRO’s perspective on planning clinical trials for global success For pharmaceutical companies preparing for global expansion, launching in both the US and EU / UK markets often seems like the natural next step. Yet success in one region does not guarantee success in the other.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
